Tagged with pfizer

Puerto Rico Giuseppe Allocca, Pfizer’s site leader for its Vega Baja & Barceloneta operations in Puerto Rico, highlights the importance of Pfizer’s manufacturing operations on the island, with 14 of the company’s key products manufactured there.   Puerto Rico boasts one of the most talented workforces in pharmaceutical manufacturing in the world,…

Sweden Sweden, home of IKEA, Pippi Longstocking and Abba, is one of Europe’s most innovative and forward-thinking nations in the healthcare and life sciences sphere. Here are five top facts to know about Sweden.   Sweden holds one of the most comprehensive sets of patient registries in the world These are…

Sweden Malin Parkler, country manager of Pfizer Sweden, breaks down the extensive footprint of Pfizer in Sweden across the value chain, lays down the advantages of Sweden as a research and manufacturing hub, and shares the exciting local collaborations and partnerships the company is developing to support healthcare and patients.  …

Thailand PharmaBoardroom last reported on Thailand in 2015, meeting country managers from across the healthcare and life sciences value chain. Here, we chart some of their career progressions since then.   Sticking with Servier Guillaume Drianno Guillaume Drianno was Thailand country manager for French firm Servier between 2013 and 2017. Prior…

Sweden The top 50 most sold drugs in Sweden for 2018. AbbVie’s Humira takes the top spot for the second year running, followed by Gilead’s Epclusa and BMS and Pfizer’s Eliquis.   Made with Visme Infographic Maker  

Pharma Pfizer, in an attempt to bolster its oncology portfolio, is set to acquire Array Biopharma for USD 10.6 billion in the second half of 2019. The deal will give Pfizer access to Array’s cancer treatments which are showing promise in phase III trials and protect it against the looming patent…

Sweden The Top 20 pharma companies in Sweden ranked by sales in 2018. Out in front is Swiss giant Novartis with approx USD 256 million in sales, followed by MSD with USD 220 million and Pfizer with USD 212 million. The companies with the highest levels of sales growth since 2017…

China On May 30th, and with much fanfare, Pfizer Upjohn officially inaugurated its global headquarters in the heart of Shanghai, China. Following a global re-organization mid-2018, Pfizer now operates three business units, namely Innovative Medicines (including biosimilars and a new hospital business unit dealing with anti-infectives and sterile injectables), Consumer Healthcare,…

Spain Sergio Rodriguez, CEO of Pfizer Spain, highlights the strength of the affiliate and the importance for the company in Europe, as well as the key areas that are driving their growth. Furthermore, he gives an overview of the need for innovative companies to partner with key stakeholders and illustrates what…

Spain Against an alluring backdrop, big-name pharma brands are now starting to spend heavily on in-country manufacturing, development and shared service facilities in Spain.   Spain has exceedingly high youth unemployment. However, the country simultaneously possesses some of the best business universities, technical schools and hospitals. This means that it is…

UK The two Big Pharma giants today announced the merger between their consumer healthcare businesses, with the joint venture (JV) set to become the global market leader in over-the-counter (OTC) products with a market share of 7.3 percent.   This move will see GSK effectively split into two separate businesses –…

Biotech Pfizer has teamed up with Bain Capital to launch Cerevel Therapeutics, a biopharmaceutical company based in Boston that will focus on developing treatments for a number of central nervous system (CNS) disorders. It has almost been a year since Pfizer announced that they were to cease R&D in new neuroscience…